SI1377574T1 - - Google Patents
Info
- Publication number
- SI1377574T1 SI1377574T1 SI200230083T SI200230083T SI1377574T1 SI 1377574 T1 SI1377574 T1 SI 1377574T1 SI 200230083 T SI200230083 T SI 200230083T SI 200230083 T SI200230083 T SI 200230083T SI 1377574 T1 SI1377574 T1 SI 1377574T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pde3
- inhibitors
- compounds
- formula
- description
- Prior art date
Links
- 101100135868 Dictyostelium discoideum pde3 gene Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Luminescent Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Pyridine Compounds (AREA)
- Electroluminescent Light Sources (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01104086 | 2001-02-21 | ||
| PCT/EP2002/001819 WO2002066476A1 (en) | 2001-02-21 | 2002-02-21 | 6-phenylbenzonaphthyridines |
| EP02722110A EP1377574B1 (en) | 2001-02-21 | 2002-02-21 | 6-phenylbenzonaphthyridines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1377574T1 true SI1377574T1 (OSRAM) | 2005-08-31 |
Family
ID=8176545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200230083T SI1377574T1 (OSRAM) | 2001-02-21 | 2002-02-21 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6936622B2 (OSRAM) |
| EP (1) | EP1377574B1 (OSRAM) |
| JP (1) | JP4248245B2 (OSRAM) |
| AT (1) | ATE287403T1 (OSRAM) |
| AU (1) | AU2002253045B2 (OSRAM) |
| CA (1) | CA2438717C (OSRAM) |
| DE (1) | DE60202669T2 (OSRAM) |
| DK (1) | DK1377574T3 (OSRAM) |
| ES (1) | ES2236504T3 (OSRAM) |
| PT (1) | PT1377574E (OSRAM) |
| SI (1) | SI1377574T1 (OSRAM) |
| WO (1) | WO2002066476A1 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005537312A (ja) * | 2002-08-17 | 2005-12-08 | アルタナ ファルマ アクチエンゲゼルシャフト | 新規のフェナントリジン |
| RS20050117A (sr) * | 2002-08-17 | 2007-06-04 | Altana Pharma Ag., | Novi benzonaftiridini |
| CA2496459C (en) | 2002-08-29 | 2013-06-25 | Altana Pharma Ag | 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| HRP20050293A2 (en) | 2002-09-04 | 2006-07-31 | Altana Pharma Ag | Novel benzonaphthyridines |
| EP1537109B1 (en) * | 2002-09-04 | 2007-04-18 | ALTANA Pharma AG | Novel benzonaphthyridines |
| ES2400823T3 (es) | 2004-02-18 | 2013-04-12 | Takeda Gmbh | Nuevas hidroxi-6-fenilfenantridinas sustituidas con guanidinilo como inhibidores eficaces de fosfodiesterasa (PDE) 4 |
| CN104803974A (zh) | 2004-03-03 | 2015-07-29 | 塔科达有限责任公司 | 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途 |
| AR049419A1 (es) * | 2004-03-03 | 2006-08-02 | Altana Pharma Ag | Hidroxi-6-fenilfenantridinas sustituidas con heterociclilo |
| KR20060130697A (ko) * | 2004-03-10 | 2006-12-19 | 알타나 파마 아게 | 신규한 아미도-치환 히드록시-6-페닐페난트리딘 및 ｐｄｅ4억제제로서의 이의 용도 |
| AU2005223386A1 (en) | 2004-03-17 | 2005-09-29 | Nycomed Gmbh | Novel N- (alkoxyalkyl) carbamoyl - substituted 6-phenyl-benzonaphthyridine derivatives and their use as PDE3/4 inhibitors |
| KR101421914B1 (ko) | 2005-03-02 | 2014-07-22 | 다케다 게엠베하 | 6-헤테로시클릴 치환된 헥사히드로페난트리딘 유도체의 신규한 염 |
| WO2018069210A1 (en) | 2016-10-10 | 2018-04-19 | Takeda Gmbh | Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL189641B1 (pl) * | 1996-11-11 | 2005-09-30 | Altana Pharma Ag | Benzonaftyrydyny, środki farmaceutyczne je zawierające oraz zastosowanie benzonaftyrydyn |
| WO1998040382A1 (en) * | 1997-03-07 | 1998-09-17 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel tetrazoles |
| AU8106598A (en) | 1997-06-03 | 1998-12-21 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Benzonaphthyridine |
| US6306869B1 (en) * | 1998-05-05 | 2001-10-23 | Byk Gulden Lomberg Chemische Febrik Gmbh | N-oxides |
| JP2002523505A (ja) * | 1998-08-31 | 2002-07-30 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | Ｐｄｅ３−及びｐｄｅ−４抑制作用を有するベンゾナフチリデン−ｎ−オキシド |
-
2002
- 2002-02-21 WO PCT/EP2002/001819 patent/WO2002066476A1/en not_active Ceased
- 2002-02-21 SI SI200230083T patent/SI1377574T1/xx unknown
- 2002-02-21 AU AU2002253045A patent/AU2002253045B2/en not_active Ceased
- 2002-02-21 US US10/467,568 patent/US6936622B2/en not_active Expired - Fee Related
- 2002-02-21 AT AT02722110T patent/ATE287403T1/de active
- 2002-02-21 ES ES02722110T patent/ES2236504T3/es not_active Expired - Lifetime
- 2002-02-21 DK DK02722110T patent/DK1377574T3/da active
- 2002-02-21 PT PT02722110T patent/PT1377574E/pt unknown
- 2002-02-21 DE DE60202669T patent/DE60202669T2/de not_active Expired - Lifetime
- 2002-02-21 JP JP2002565990A patent/JP4248245B2/ja not_active Expired - Fee Related
- 2002-02-21 CA CA2438717A patent/CA2438717C/en not_active Expired - Fee Related
- 2002-02-21 EP EP02722110A patent/EP1377574B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20040097537A1 (en) | 2004-05-20 |
| ES2236504T3 (es) | 2005-07-16 |
| ATE287403T1 (de) | 2005-02-15 |
| AU2002253045B2 (en) | 2007-07-12 |
| EP1377574A1 (en) | 2004-01-07 |
| CA2438717C (en) | 2011-08-30 |
| DE60202669T2 (de) | 2005-09-15 |
| WO2002066476A1 (en) | 2002-08-29 |
| DE60202669D1 (de) | 2005-02-24 |
| EP1377574B1 (en) | 2005-01-19 |
| DK1377574T3 (da) | 2005-04-25 |
| WO2002066476A9 (en) | 2003-10-30 |
| US6936622B2 (en) | 2005-08-30 |
| JP2004526712A (ja) | 2004-09-02 |
| JP4248245B2 (ja) | 2009-04-02 |
| PT1377574E (pt) | 2005-05-31 |
| CA2438717A1 (en) | 2002-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1070056T1 (en) | Phthalazinone pde iii/iv inhibitors | |
| WO2004018431A3 (en) | Novel phenanthridines | |
| DE60310576D1 (en) | 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer | |
| MXPA02009567A (es) | Benzoilpirzoles y su uso como herbicidas. | |
| PL372926A1 (en) | Piperidine-pyridazones and phthalazones as pde4 inhibitors | |
| DE60311662D1 (en) | 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren | |
| WO2004018465A3 (en) | Benzonaphthyridines with pde 3/4 inhibiting activity | |
| MXPA03008754A (es) | Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor. | |
| WO2004018451A8 (en) | Pyridazinone-derivatives as pde4 inhibitors | |
| WO2002085906A3 (en) | Phthalazinones derivatives useful as pde4/7 inhibitors | |
| PL369530A1 (en) | Chemical compounds | |
| MXPA04003886A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplasticos. | |
| GB9929552D0 (en) | Compounds | |
| AU2001274220A1 (en) | Serine protease inhibitors | |
| GB0114185D0 (en) | Compounds | |
| MXPA03006224A (es) | Inhibidores de cruzipaina y otras proteasas de cisteina. | |
| MXPA03009750A (es) | Compuestos quimicos. | |
| AU2001264065A1 (en) | Serine protease inhibitors | |
| MY133969A (en) | Indoloquinazolinones | |
| SI1086096T1 (en) | Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors | |
| AU2001264081A1 (en) | Serine protease inhibitors | |
| SI1377574T1 (OSRAM) | ||
| TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
| MXPA04003755A (es) | Endoprotesis vasculares. | |
| MY128164A (en) | Compounds |